214 SYSTEMS BIOTECHNOLOGY by Sang Yup Lee
214 
 
SYSTEMS BIOTECHNOLOGY 
SANG YUP LEE
1  
leesy@kaist.ac.kr 
  
1  Department of Chemical and Biomolecular Engineering (BK21 Program), BioProcess 
Engineering Research Center, Bioinformatics Research Center, Center for Systems and 
Synthetic Biotechnology, Institute for the BioCentury, KAIST, Daejeon 305-701, Korea 
Systems biology has been changing the way biological and biotechnological research is performed. 
Now, systems biological approaches can be taken to develop bioprocesses for the production of 
valuable drugs, commodity and fine chemicals, fuels, and polymers and other materials; this is 
termed systems biotechnology. Here I present the general strategies for systems biotechnology and 
several examples of applying systems biotechnological strategies for the development of 
bioprocesses for the efficient production of chemicals and materials. This also includes a strategy of 
systems metabolic engineering for the development of microbial strains. It is expected that systems 
biotechnology will be at the heart of successful industrial biotechnology towards low carbon green 
growth of the world 
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1.  Strategy of Systems Biotechnology 
Systems biotechnology [1] can be defined, following the OECD definition of 
biotechnology, as the application of science and technology at systems level to living 
organisms as well as parts, products and models thereof, for the production of knowledge, 
goods and services. As we become equipped with many experimental and computational 
tools and methods, we can better understand the cell as a whole. A typical bioprocess for 
the production of a desired product will rely on the choice of a main substrate (e.g., 
carbon source), development of superior microorganism through metabolic engineering, 
fermentation, and downstream processing for product recovery [2]. These unit processes 
need to be optimized in an integrated manner to achieve the best performing process [3]. 
Systems biology contributes significantly to the strain development through metabolic 
engineering; thus it is called systems metabolic engineering [3-5]. Of course, midstream 
(fermentation) and downstream processes need to be carefully examined so that strains 
can be further engineered for the best overall performance. This means that some of the 
problems encountered during the mid- to down-stream processes can be tackled by 
further metabolic engineering based on systems-level analysis [3,6].  
 
2.  Systems Metabolic Engineering 
Systems metabolic engineering [3-6] allows purposeful modification of metabolic, gene 
regulatory, and signaling networks based on systems-level analysis. One can set the 
objective as enhanced production of a desired product, production of novel product, or  Systems Biotechnology   215 
utilization of inexpensive carbon source, or all of these. In addition to all the tools and 
methods of metabolic engineering available, omics and computational methods [7,8] can 
be applied to the development of superior strains. Here I will give examples on the 
development of amino acid producers [4,6,9,10], diamine producer [11], succinic acid 
producer [12], and polymer producer  [13,14] by systems metabolic engineering. If time 
permits, the strategies for drug target discovery by systems approach [15-17] will also be 
described. 
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